Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02347683 · ClinicalTrials.gov registry record
Optimal Measurement of Thyroglobulin Measurement Following Thyroidectomy
A clinical trial, sponsored by University of Nebraska.
- Completed
- Registry status
- 50
- Enrollment target
NCT02347683 is a clinical trial that has completed, run by University of Nebraska. The registered enrollment target is 50 participants.
The verdict
NCT02347683 has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The optimal timing to measure thyroglobulin(Tg) after thyroidectomy is unknown in patients with thyroid cancer. The ATA and NCCN guidelines are not specific on optimal timing of Tg levels in post-op state and suggest anywhere between 2-12 weeks. Hypothesis - Post -op Tg nadirs at 6-8 weeks . Primary Objective -Determine optimal timing of post thyroidectomy Tg nadir, so to determine the most accurate time to check post operatively. Secondary Outcome - Determine factors that will affect Tg levels post operatively. All adults age 19 and above already planning to undergo near total /total thyroidectomy for reasons unrelated to the study. Measure Tg , Tg Ab and TSH pre-op, post op ---\> 7-14 days, 4 wk, 6 wk, and 3 month in patients with pathology confirmed benign disease. Measure Tg , Tg Ab , TSH pre-op, post op ---\> 7-14 days, 4 wk, 6 wk, 3 month, 6 month, and 12 month in patients with thyroid cancer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2015-01-01 |
| Est. Completion | 2016-02-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02347683
The ClinicalTrials.gov registry entry for NCT02347683 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02347683 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02347683 about?
NCT02347683 is a clinical study titled "Optimal Measurement of Thyroglobulin Measurement Following Thyroidectomy". The optimal timing to measure thyroglobulin(Tg) after thyroidectomy is unknown in patients with thyroid cancer. The ATA and NCCN guidelines are not specific on optimal timing of Tg levels in post-op state and suggest anywhere between 2-12 weeks. Hypothesis - Post -op Tg nadirs at 6-8 weeks . Prima...
What is the current status of trial NCT02347683?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2015-01-01. Estimated completion is 2016-02-01.
Who is sponsoring clinical trial NCT02347683?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.